• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Histopathology. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings

tetano

Editor, Senior Moderator
Histopathology. 2020 May 4. doi: 10.1111/his.14134. [Epub ahead of print]
Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction.


Menter T[SUP]1[/SUP], Haslbauer JD[SUP]1[/SUP], Nienhold R[SUP]2[/SUP], Savic S[SUP]1[/SUP], Hopfer H[SUP]1[/SUP], Deigendesch N[SUP]1[/SUP], Frank S[SUP]1[/SUP], Turek D[SUP]2[/SUP], Willi N[SUP]2[/SUP], Pargger H[SUP]3[/SUP], Bassetti S[SUP]4[/SUP], Leuppi JD[SUP]5[/SUP], Cathomas G[SUP]2[/SUP], Tolnay M[SUP]1[/SUP], Mertz KD[SUP]2[/SUP], Tzankov A[SUP]1[/SUP].

Author information




Abstract

AIMS:

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly evolved into a sweeping pandemic. While its major manifestation is in the respiratory tract, the general extent of organ involvement as well as microscopic changes in the lungs remain insufficiently characterised. Autopsies are essential to elucidate COVID-19-associated organ alterations.
METHODS:

This study reports autopsy findings of 21 COVID-19 patients hospitalised at the University Hospital Basel and at the Cantonal Hospital Baselland, Switzerland. An in-corpore technique was performed to ensure optimal staff safety.
RESULTS:

The primary cause of death was respiratory failure with exudative diffuse alveolar damage with massive capillary congestion often accompanied by microthrombi despite anticoagulation. Ten cases showed superimposed bronchopneumonia. Further findings included pulmonary embolisms (n=4), alveolar haemorrhage (n=3) and vasculitis (n=1). Pathologies in other organ systems were predominantly attributable to shock; three patients showed signs of generalised thrombotic microangiopathy. Six patients were diagnosed with senile cardiac amyloidosis upon autopsy. Most patients suffered from one or more comorbidities (hypertension, obesity, cardiovascular diseases, diabetes mellitus). Additionally, there was an overall predominance of males and individuals with blood group A (81% and 65%, respectively). All relevant histological slides are linked as open-source scans in supplementary files.
CONCLUSIONS:

This study provides an overview of post-mortem findings in COVID-19 cases, implying that hypertensive, elderly, obese, male individuals with severe cardiovascular comorbidities as well as those with blood group A may have a lower threshold of tolerance for COVID-19. This provides a pathophysiological explanation for higher mortality rates amongst these patients.
This article is protected by copyright. All rights reserved.



KEYWORDS:

SARS-CoV-2; autopsy; cardiovascular; lung; senile amyloidosis


PMID:32364264DOI:10.1111/his.14134
 
Back
Top Bottom